作者: Leandro J. Bertoglio , Antonio P. Carobrez
DOI: 10.1007/S00213-003-1558-Z
关键词: GABAA receptor 、 Glycine receptor 、 Mechanism of action 、 Anxiolytic 、 Elevated plus maze 、 Internal medicine 、 Endocrinology 、 NMDA receptor 、 Chemistry 、 Receptor 、 Pharmacology 、 Glycine
摘要: Rationale Drugs enhancing the GABAA and/or reducing NMDA/glycine-B receptor activity produce an anxiolytic effect. Regarding former drugs (e.g. benzodiazepines), prior elevated plus-maze (EPM) test experience abolishes trial 2 activity, a phenomenon referred to as "one-trial tolerance" (OTT).